Day: September 29, 2021

BOSTON, Sept. 29, 2021 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea together with other members of the Atea management team, will participate in a fireside chat at the Guggenheim 2nd Annual Vaccines & Infectious Day Conference on Tuesday, October 5, 2021 at 9:30 a.m. ET. A live webcast of the presentation will be available here and on the Company’s website at www.ateapharma.com. A replay of the webcast will be available for 90 days following the presentation. About Atea Pharmaceuticals Atea Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing oral therapies to address the unmet medical needs of patients...

Defined, prospective Cu-Mo-Au Porphyry targets in highly fertile Miocene belt Encouraging early exploration results warrant follow up drillingVANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to report on the exploration results on its 100% owned Osiris Cu project (“Osiris”), located within the fertile Miocene belt of Chile which is host to several high-profile advanced projects such as Altar, Los Azules, El Pachon and Pelambres, among others. Osiris was staked by Mirasol through its project generation program and comprises approximately 10,000 ha of exploration claims. Mirasol’s detailed surface exploration has defined two drill-ready concealed porphyry Cu-Mo-(Au) targets. Mirasol’s President, Tim Heenan, commented: “We are...

Results from KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus to be presented STAMFORD, Conn., Sept. 29, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs), today announced that results from the KARE Phase 2 clinical trial of Oral KORSUVA™ (difelikefalin tablets) for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis (AD) patients will be presented in a late-breaking presentation at the European Academy of Dermatology and Venereology (EADV) 30th Anniversary Congress, held virtually from September 29-October 2, 2021. Details for the late-breaking oral...

Global WholeHealth Partners Corp (GWHP) is confident in the new partnerships to produce the best COVID Antigen test on the market. San Clemente, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — COVID Antigen testing is not going away and has become the new test and vaccine for years to come.   Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses.  The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer...

– Improvements in two additional assessments of pulmonary function in treated patients compared with untreated control patients further support potential functional benefit of SGT-001 one-year post administration – – Data presented at the Child Neurology Society 50th Annual Meeting – CAMBRIDGE, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today reported additional positive pulmonary function data from the first six patients in the ongoing IGNITE DMD Phase I/II clinical trial of SGT-001. Oscar H. Mayer, MD, Attending Pulmonologist and Director of the Pulmonary Function Laboratory at Children’s Hospital of Philadelphia, is presenting the data in a poster session (Abstract...

MÜV Pinellas Park is Verano’s 38th Florida storefront, and the Company’s 86th nationwide. Verano has opened nine new retail locations in Florida this year and plans to add up to four additional stores in the Sunshine State during Q4 2021. The new MÜV dispensary is located on Park Boulevard North near the Belcher Road intersection, a retail corridor which sees average daily traffic of nearly 50,000 cars, according to the Florida Department of Transportation. The city of Pinellas Park is home to approximately 50,000 residents, per a 2020 U.S. Census Bureau estimate, centered between the adjacent Clearwater and St. Petersburg metropolitan areas, and is just minutes away from the Tampa Bay waterfront and Pinellas County Aquatic Preserve.CHICAGO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano”...

CARSON CITY, NV, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), is pleased to update its shareholders on the company’s Regulation A offering and ongoing progress with the California acquisition previously announced in a news release published on August 12, 2021. The SEC’s notice of qualification with respect to the Reg A offering was issued on September 24, 2021. A portion of the proceeds from this offering will be used to complete the acquisition of the California based Cannabis Licensed Company and to construct state-of-the-art greenhouse on the 12 acres. Upon closing of the aforementioned acquisition, the Company intends to apply to the State of California for a Cannabis nursery license to enable it to develop its Tissue Culture Starter Plantlet production facility....

LAS VEGAS, NV, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — GZ6G Technologies Corp. (OTCMARKETS: GZIC), the next generation wireless smart venue engagement technology, and venue data analytics company for large venues, focused on customers’ experience, game day venue intelligence, data insights and artificial intelligence (AI) to enhance stadiums, airports, universities and cities’ capabilities to connect and manage communication with thousands of fans, customers and visitors simultaneously, has today announced that its Registration Statement on Form S-1 (the “Registration Statement”), in connection with its previously announced plans to raise $5 million to support its future business developments, has been declared effective by the U.S. Securities and Exchange Commission (“SEC”) as of Friday, September 24, 2021....

Figure 1Plan view showing zones of significant intercepts for GWUG21-008, 010 and 011 indicating NW continuity of mineralization within shear zones.Figure 2Cross section A-A’ within 10 meters projection volume showing zones of significant intercepts for GWUG21-008, 010 and 011VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — Scorpio Gold Corporation (“Scorpio Gold” or the “Company”) (TSXV: SGN) is pleased to announce results from 5 holes drilled to test the northwestern extension of mineralization at the 100% owned Goldwedge property, located in Nevada. The current program is focused on defining the on-strike and down-dip continuity of mineralization intersected in the 2020 drilling program (July 27, 2020 news release) as well as testing new areas with the potential to define a mineral...

Alabama Board of Dental Examiners Can No Longer Impede the Company’s Telehealh Platform or Affiliated Dentists and Orthodontists From Providing Clear Aligner Therapy in the State NASHVILLE, Tenn., Sept. 29, 2021 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), a next generation oral care company with the first medtech platform for teeth straightening, today announced its gratitude to the Federal Trade Commision (FTC) for its actions to combat anti-competitive conduct in Alabama. The proposed Consent Order will ensure that consumers in Alabama will have access to efficacious and cost effective clear aligner therapy treatment using the innovative SmileDirectClub telehealth platform. Under the proposed Consent Order, the Alabama Board of Dental Examiners can no longer impede clear aligner platforms, or dental professionals...